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Abstract: The water surface microlayer is still poorly explored, although it has been shown to 
contain a high density of metabolically active bacteria, often called bacterioneuston. 
Actinomycetes from the surface microlayer in the Trondheim fjord, Norway, have been 
isolated and characterized. A total of 217 isolates from two separate samples morphologically 
resembling the genus Streptomyces have been further investigated in this study. Antimicrobial 
assays showed that about 80% of the isolates exhibited antagonistic activity against non-
filamentous fungus, Gram-negative, and Gram-positive bacteria. Based on the macroscopic 
analyses and inhibition patterns from the antimicrobial assays, the sub-grouping of isolates 
was performed. Partial 16S rDNAs from the candidates from each subgroup were sequenced 
and phylogenetic analysis performed. 7 isolates with identical 16S rDNA sequences were 
further studied for the presence of PKS type I genes. Sequencing and phylogenetic analysis of 
the PKS gene fragments revealed that horizontal gene transfer between closely related species 
might have taken place. Identification of unique PKS genes in these isolates implies that de-
replication can not be performed based solely on the 16S rDNA sequences. The results 
obtained in this study suggest that streptomycetes from the neuston population may be an 
interesting source for discovery of new antimicrobial agents. 
 
Keywords:  Sea surface microlayer, streptomycetes, antimicrobial activity, phylogenetic 
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1. Introduction 
Search for new biologically active microbial secondary metabolites is important in order to meet the 
increasing demand for new antibiotics. Actinomycetes, especially those belonging to the genus 
Streptomyces, are known to produce a wide variety of biologically active compounds. Streptomyces 
bacteria were reported to produce ~70% of the currently characterized actinomycete natural products 
[1]. However, most of the Streptomyces characterized up to date were isolated from the terrestrial 
environment, while those originating from marine sources still remain poorly explored. 
In an environment with high densities of metabolically active bacteria, competition is likely to be 
fierce, and properties such as production of antibiotics may give organisms an advantage. A number of 
antibiotic producers have been isolated from the marine environments [2, 3], and experimental data 
indicate that production of antibiotics could play an important role in the competitive relationship 
within the marine bacterial populations [4]. Antagonistic interactions among soil-living 
microorganisms are well documented, and are attributed to the production of antibiotics by certain 
bacteria and fungi in environments rich in organic material [5, 6]. Recently, the same trend has been 
discovered for marine microorganisms, which are abundant in mesotrophic and eutrophic waters or 
during phytoplankton blooms [7]. 
In a study of antagonistic interactions among marine pelagic bacteria it was found that more than 
half of the isolates expressed antagonistic activity, and this trait was more common among particle-
associated (66%) than free-living bacteria (40%) [8]. Particles often tend to accumulate at the sea 
surface, and the aquatic surface layer contains a series of sub layers [9]. Neuston is a collective name 
for the life forms in the surface layer of oceans and lakes, and can be divided into epineuston and 
hyponeuston. Epineuston organisms live on the top of the water surface, and are naturally dependent 
on the surface tension of the water. Hyponeuston organisms live in the top few centimetres of the 
water column. High densities of metabolically active bacteria, often called bacterioneuston, are found 
in the surface microlayer [10-13].  
Norwegian marine ecosystems have developed in a rather cold and severe climate, suggesting that 
the selective pressure on microorganisms comprising parts of such systems must have been quite 
unique (cold seawater environment). Because of this, it seems likely that these microorganisms have 
developed antibiotic biosynthesis pathways that differ from those utilized by terrestrial 
microorganisms. Even though the diversity of microorganisms in the marine environment is high, only 
a minor fraction (less than 1 %) can be cultivated in the laboratory, presumably because of failure to 
mimic the natural growth conditions [14]. In this work we isolated Streptomyces bacteria from the 
surface microlayer in the Trondheim fjord (Norway). The isolates were characterized using molecular 
taxonomy, assays for antimicrobial activity and presence of polyketide synthase genes. 
2. Results and Discussion 
2.1. A large proportion of cultivable neuston actinomycetes produce antimicrobial compounds 
Bacteria morphologically similar to streptomycetes were isolated from surface microlayer collected 
at Steinvikholmen (a small islet) and in the Åsen fjord in the Trondheim fjord, Norway. The water Mar. Drugs 2008, 6 
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temperatures during sampling were 4.3 and 5.8 °C, respectively, and the air temperature was 3 °C in 
both cases. Water was sampled from two sites, both to increase the number of isolates and to possibly 
detect any spatial variations in diversity. Collecting water samples close to the shore increases the risk 
of cultivating terrestrial bacteria that have been washed into the sea. Initial isolation of the bacteria 
was therefore performed on agar media with 50 % seawater to increase the chance of isolating bacteria 
adapted to the marine environment. 
Total numbers of bacteria isolated on Actinomycete isolation seawater agar with cycloheximide and 
nalidixic acid added to inhibit the growth of fungi and Gram-negative bacteria, were 2.5x10
3 and 
1.2x10
4 cells/ml seawater from the two sites, respectively. Presumed actinomycetes (based on colony 
morphology) accounted for 9.8x10
2 and 1.3x10
3 cells/ml, respectively. From these, a total of 217 
colonies from samples 1 and 2 represented by 134 and 83 isolates, respectively, were selected for 
further analyses. 
Previously, it has been reported that bacteria isolated from the surface microlayer at coastal stations 
in the north-western Mediterranean Sea, contained an average of Gram-positive cultivable bacteria 
ranging from 2.3x10
3 (France)
 to 3.0x10
4 (Spain) ml
-1 [15], indicating that the cell number can vary 
considerably depending on the sampling site. Based on these reports, the total number of isolates in the 
samples collected in this study is assumed to reflect at least some of the diversity in the Trondheim 
fjord.  
Based on the colony morphology (colour of substrate and aerial mycelia, pigment production), the 
isolates could be divided into 10 groups, shown in Table 1. 
Table 1. Characteristics of the different isolate groups, when grown on ½ISP2 medium 
with 50% seawater for up to 14 days. SM = substrate mycelium, AM = aerial mycelium  
Group Characteristics 
SM AM  Other 
1  Colourless White   
2  Colourless  White  Produces yellow metabolite diffusing in solid media 
3  Colourless Greenish-white   
4  Colourless  Greenish-white  Produces yellow metabolite diffusing in solid media 
5  Light brown  Light grey   
6  Brown /greenish  Grey   
7  Colourless /light brown  Light purple   
8  Red None   
9  Red White   
10  Yellow None  Flaky 
 
Cultivation of the isolates on agar medium with and without seawater, showed that they all grew 
better/faster on media with 50 % seawater added, as exemplified on Figure 1. Actinomycetes isolated 
from marine sediments have earlier been analyzed for their seawater requirement for growth [16]. The 
detected requirement has been interpreted as indication of marine origin or marine adaptation. None of 
the isolates in this study demonstrated inhibited growth on salt-containing media, suggesting that all Mar. Drugs 2008, 6 
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isolates are marine bacteria or terrestrial bacteria adapted to the marine environment, and presumably 
occur naturally in the surface microlayer.  
Figure 1. Growth of isolated actinomycetes after 7 days of incubation at 30 ˚C on ½ ISP2 
agar with (A) and without (B) 50% seawater. 
                                A                                      B 
 
 
 
 
     
 
 
    
 
In order to explore the potential of the isolates to produce antimicrobial compounds, extracts from 
the colonies grown on three different solid agar media were tested in microbial inhibition assays. After 
an appropriate incubation time (depending on the growth rate), the plates with cells were dried, and 
extracted with DMSO. The extracts were tested in agar diffusion assays for antimicrobial activity. The 
initial assays were performed with Micrococcus luteus ATCC 9341, Candida albicans ATCC 10231 
and Escherichia coli K12 as indicator organisms. The antimicrobial activity, presented in Table 2, is 
the total combined activity displayed by the isolates when grown on any of the 3 agar media. As 
expected, a high share of the isolates exhibited antimicrobial activity. In particular, 79% of the sample 
1 isolates, and 85% of the sample 2 isolates showed antagonistic activity against at least one of the 
indicator organisms. Several of the isolates showing antimicrobial activity were active against more 
than one indicator organism, as shown in Table 2. This was particularly evident for the isolates with 
antibacterial activity, where around 80% of the isolates inhibiting Gram-negative bacteria also 
inhibited Gram-positive bacteria, and vice versa. Table 2 shows how the different inhibition patterns 
are distributed among the isolates from different morphological groups. The fact that some isolates 
displayed activity against more than one indicator organism may indicate production of several 
antimicrobial compounds and/or production of compounds with multiple microbial targets. 
The percentage of neuston actinomycete isolates displaying antimicrobial activity was found to be 
considerably higher than those reported previously. In the earlier studies, about 50% of isolated marine 
pelagic bacteria exhibited antagonistic properties against other pelagic bacteria [8], and only 44 % of 
streptomycetes from the marine sediments have shown antibacterial activity [17]. In the latter study, 
17% of the isolates displayed antifungal activity. A noticeably lower degree of antifungal compared to 
antibacterial activity among Streptomyces species isolated from marine sediments has also been 
reported by [18]. In our study, about 40% of the assumed (based on morphology and inhibition 
patterns) non-identical isolates from both sample 1 and 2 showed antifungal activities.  
 Mar. Drugs 2008, 6 
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Table 2. Total number of streptomycete-like isolates from bacterioneuston, sample 1 and 
2, grouped and sub-grouped according to antimicrobial activity and colony morphology. 
DMSO-extracts from all strains were tested for activity against C. albicans (C), M. luteus 
(M) and E. coli (E). Samples 1 and 2 contain 134 and 83 isolates, respectively S1 and S2 
indicate sample 1 and sample 2, and G1-G10 indicate morphology groups 1- 10, (see Table 
1). The percentages (S1 and S2 combined) of antifungal, antibacterial and no activity in 
each of the groups, G1-G10, are also given. 
  
Inhibition
N rC M E S 1S 2S 1S 2S 1S 2S 1S 2S 1S 2S 1S 2S 1S 2S 1S 2S 1S 2S 1S 2  Total
1x x x 67015020100000140200 2 9
2x x 61000000001000000000 8
3x x 94000000100000000000 1 4
4x 2 8 1 4 400200433300010000 6 2
5x x 47132272100100283110 4 5
6x 52000100000020000010 1 1
7 x 20000040110000000000 8
8 1 2 7201000547200000000 4 0
72 42 7 4 8 5 13 2 13 8 11 6 2 0 3 13 3 3 2 0 217
G8 G9 G10
Group (G1-10) and sample number (S1, S2)
G1 G2 G3 G4 G5 G6 G7
0 66
46
45 54 0
45 77 100 24 12 100 94
13 43
0
100 100
17 18 8 0 43 53 0
2
Sum, no of isolates
Sum, no of isolates 21 17 2 16 114 11 13
Antifungal (%)
Antibacterial (%)
No activity (%)
6 15
0 0
38 33 41
 
 
The methods chosen for surface sampling and cultivation may facilitate isolation of some types of 
bacteria over others. This will affect both the quantity and the diversity of the samples. Isolates from 
group G1 were frequently found in both samples. This may be due both to the fact that the selected 
growth conditions were best suited for the G1 isolates, and that they were in fact abundant in the 
surface microlayer. The diversities of streptomycete-like bacteria within the samples 1 and 2, at least 
as judged from colony morphology and inhibition patterns, were quite similar. This is probably not 
surprising, considering that the currents in the fjord continuously mix the water, thereby homogenizing 
the content of bacterioneuston to some extent.  
Groups G5 and G6 had the highest share of isolates without any detectable antimicrobial activity 
under the conditions used. About half of these isolates displayed neither antifungal nor antibacterial 
activity. In both groups, one third of the isolates showed antifungal activity. Similarity in inhibition 
patterns was also noticeable between the G8 and G9 isolates. In these two groups, all isolates exhibited 
antimicrobial activity, whereof two thirds showed activity against both M. luteus and E. coli, and the 
rest also had activity against C. albicans. In addition G3 and G4 isolates showed a high degree of 
antibacterial activity, 77 % and 100 %, respectively. In total these results display a weak connection 
between morphology and antimicrobial activity to some extent.  
 
Analysis of the 16S rDNA from the isolated bacteria reveals discrepancy between phenotypic grouping 
and the molecular taxonomy. 
In order to reveal the diversity among isolated actinomycetes, a limited analysis of 1351 nt 16S 
rDNA gene fragments was performed. In total, 16S rDNA fragments from 46 isolates representing Mar. Drugs 2008, 6 
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different groups distinguishable by morphology and inhibition patterns were amplified and sequenced. 
Alignment of the sequences showed a relatively high degree of homology within the candidate 
collection, suggesting replication of some isolates. However, several of the isolates representing 
potential replicates based on the 16S rDNA sequence, displayed unique inhibition patterns, indicating 
that they are not identical.  
BLAST searches for the obtained sequences showed that the 16S rDNAs from all except 4 isolates 
had at least 99 % identity to sequences from Streptomyces spp isolated from marine sediments and 
sponges [19-22]. A widespread distribution of these bacteria in marine environments is consistent with 
the fact that they thrive on the salt-containing media.  
A phylogenetic analysis of the partial 16S rDNA sequences, displayed in Figure 2, was performed 
to reveal the taxonomic relationship between the different subgroups. In cases where several isolates 
had identical sequences, only one sequence was included in the analysis, without regard to differences 
in the morphology and inhibition patterns. As noted above, at least 10 morphologically different 
groups could be distinguished among the isolates. No clustering of these groups was observed in the 
phylogenetic analysis. Only minor grouping of isolates sharing the same inhibition patterns could be 
found. However, some clustering of isolates displaying either antifungal or antibacterial activity could 
be identified. In several cases, the “closest match” strains were reported to have antimicrobial activity 
that may be interesting from a commercial point of view.   
Sequence for the isolate MP7A10 represents a group of six isolates, whereof five appear to have the 
same morphology (group G6). These isolates display different inhibition patterns, strongly suggesting 
that 16S rDNA gene sequences alone can not be used for dereplication of isolates.  
Sequence for the isolate MP6A8 represents ten isolates with varying morphology (group G1-G5 and 
G10), of which eight were shown to have antibacterial activity. Including the remaining isolates in 
branch 1, a total of 17 out of 23 isolates in this branch displayed antibacterial activity, of which 15 
were active against Gram–positive, and 2 against Gram-negative bacteria. 
Three out of four isolates in branch 3 displayed antibacterial activity. The deviating isolate did not 
show any antimicrobial activity under the conditions tested. Sequence for isolate MP7E8 represents an 
additional isolate with the same inhibition pattern. Branch 4 and 5 consisted of isolates displaying both 
varying morphology and inhibition patterns. Isolate MP5D9 represents a group of 13 isolates whereof 
8 displayed antifungal activity. There was a considerable variation in morphology among these 
isolates.  
Several of the isolates with antibacterial activity (MP8F7, MP7E10, MP7B7, MP7E8 and MP9C8) 
showed 99 and 100% identity to Streptomyces species isolated from coastal sediments [19], but no 
antimicrobial activity has been reported for these species.  
The sequence from isolate MP5F10 having antifungal activity showed 99% identity to Streptomyces 
olivoviridis and Streptomyces sp. N0028. The cultural appearance of S. olivoviridis agrees with that of 
MP5F10. This strain has been shown to produce a new antitumor antibiotic, thioviridamide, 
stimulating apoptosis signalling [23].  
16S rDNA from the isolate MP9D2, which inhibits growth of Gram-positive bacteria, was 100% 
identical to that of S. drozdowiczii and Streptomyces sp. WL-2 (1351 bases). S. drozdowiczii NRRL B-
24297 was reported to have cellulolytic activity [24], while Streptomyces sp. WL-2 produces xylanase 
[25].  Mar. Drugs 2008, 6 
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Figure 2. Phylogenetic tree constructed for partial 16S rDNA sequences (1351 bp) of 46 
streptomycetes isolated from the surface microlayer in the Trondheim fjord, Norway. The 
tree also contains some of the closest matches from BLAST searches. The 16S rDNA 
sequence from Micromonospora sp DSM 44397 is included to root the tree. Numbers in 
brackets (x-y-z) refers to x: morphology group, y: inhibition pattern (see table 2), and z: 
sample number. Arrows indicate the different branches of the tree. Bold font indicates 
sequences representing several isolates. Strains of marine origin are underlined. 
    
 MP5H12 (5-1-1)
 Streptomyces microflavus XSD-113
 MP6A8 (3-1-1)
 MP8E12 (5-5-1)
 Streptomyces sp. N0077
 Streptomyces sp. A152 Ydz-ZZ
 Streptomyces sp.8-2
 MP7A10 (6-8-1)
 Streptomyces sp. CNT-074 SF06 
 MP7B7 (1-5-1)
 MP7E10 (4-5-2)
 MP8F7 (5-7-2)
 MP5F10 (5-4-2)
 Streptomyces sp. N0038
 MP8F10 (5-8-2)
 S.zaomyceticus XSD-118
 MP9D2 (1-7-1)
 Streptomyces drozdowiczii
 MP9D1 (1-8-1)
 MP7E8 (1-6-1)
 MP7A8 (5-8-1)
 Streptomyces sp. S240
 MP5G12 (1-3-1)
 MP5D10 (9-5-2)
 Streptomyces krainskii  XSD-107
 MP5D9 (1-1-2)
 Streptomyces sp. L116
 Micromonospora sp DSM 44397
66
90
71
90
99
99
97
67
66
61
35
48
67
99
98
48
94
65
99
0.01 
 
  16S rDNA from the isolate MP8F10 was 99% identical to S. zaomyceticus XSD-118. Different S. 
zaomyceticus strains have been shown to produce foroxymithine, narbomycin, picromycin and 
methymycin. Foroxymithine is an inhibitor of angiotensin-converting enzyme produced by 
actinomycetes, and may be of interest for medical use [26]. 16S rDNA from the isolate MP5H12 
shows 99 % similarity to S. microflavus 173958.  
Branch 1 
Branch 2 
Branch 3 
Branch 4
Branch 5 Mar. Drugs 2008, 6 
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2.3. Analysis of PKS gene fragments from selected streptomycetes isolates suggests horizontal gene 
transfer between closely related species 
Polyketide synthases (PKSs) and/or non-ribosomal peptide synthetases (NRPSs) or a combination 
of these, are involved in production of many antimicrobial secondary metabolites in Streptomycetes 
and other bacteria, fungi, and plants. Screening for and analysis of PKS-I, PKS-II and NRPS genes in 
marine metagenomic libraries as well as soil samples have earlier been reported [27-30]. These 
analyses have been performed both to elucidate diversity and to pre-screen soil samples for identifying 
the ones most likely to contain producers of novel bioactive molecules.  
  Based solely on the 16S rDNA sequence analysis of our isolates, several of them seemed to be 
very closely related (i.e. had 100 % identical 16S rDNA fragments). At the same time, they showed 
different inhibition patterns in addition to displaying different morphology (Table 3). This fact 
prompted us to investigate the presence of PKS type I genes in a selected group of such isolates, which 
were chosen without considering morphology. In the phylogenetic analysis of 16S rDNA sequences 
(Figure 2), these isolates are represented by the isolate MP6A8 in branch 1.  
Table 3. Names and inhibition patterns of isolates selected for PKS analysis. Activity is 
shown against C. albicans (C), M. luteus (M) and E. coli (E). Morphology group and 
sample number are indicated. 
Isolate 
Morphology  
group 
Sample  
number 
Inhibition 
C M E 
MP6A2 G4  S1   x  x 
MP6A8 G3  S1 x x x 
MP6C6 G4  S1   x  
MP6C10 G1  S1 x x   
MP6D1 G2  S1 x    
MP8E7 G10  S1     x 
MP9E12 G1  S2     
 
Bacterial type I (modular) PKS gene fragments were amplified with the degenerate primers KSMA-
F and KSMB-R [31], which can be used to amplify β-ketoacyl synthase (KS) domain encoding 
fragments of ca 700 bp. PCR with these primers resulted in amplification of fragments of expected size 
from all isolates, indicating their potential for production of polyketide secondary metabolites. Since 
PKS type I genes encode modular enzymes, and actinomycete strains usually contain more than one 
PKS gene cluster [28], it was expected that PCR products obtained with the KS-specific primers would 
represent mixtures of the KS-coding sequences. Therefore, sequencing of these gene fragments would 
be required for a better understanding of the diversity within the selected group of isolates and their 
dereplication.  
PKS type I PCR fragments were cloned in Escherichia coli vector, and for each isolate 12 clones 
were sequenced. A total of 13 different sequences were obtained from 7 selected isolates. Six different 
KS-encoding sequences were amplified from the total DNA of the isolate MP8E7. BLAST search of Mar. Drugs 2008, 6 
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the corresponding amino acid sequences revealed that fragments PKSI-1 and PKSI-6 from this isolate 
encode 95% identical KS domains showing 83% identity to the KS domain of MerC, a PKS involved 
in biosynthesis of the neuroprotectant meridamycin in S. violaceusniger [32]. The amino acid 
sequences for PKSI-2 and -3 fragments displayed 72% and 71% identity, respectively, to the PKS 
from  Saccharopolyspora erythraea (unknown product) [33] and PteA2 PKS responsible for 
biosynthesis of antifungal polyene macrolide filipin in S. avermitilis [34]. Amino acid sequences of the 
PKSI-1, 2, 3 and -6 products were 68% to 95% identical, and might have been amplified from the 
same PKS gene cluster. The PKSI-4 and -5 fragments amplified from MP8E7 were quite different 
from each other and from the rest of the PKS sequences from this isolate. The amino acid sequence for 
PKSI-4 displayed 72% identity to the PKS from Amycolatopsis orientalis involved in the biosynthesis 
of the antibacterial compound ECO-0501 of a new chemical class [35]. The amino acid sequence for 
PKSI-5 displayed 96% identity to the PKS part of the NRPS-PKS fusion protein from Streptomyces 
griseus subsp. griseus NBRC 13350 (NC_010572.1) 
The isolates MP6A2 and MP6D1 yielded 2 PKS sequences each. Both on the nucleotide and amino 
acid levels, MP6A2 PKSI-1 and MP6D1 PKSI-1 sequences were 100% identical to each other, and 
shared 83% identity with S. coelicolor cryptic PKS type I [36] The identity of the sequences suggests 
recent horizontal gene transfer between the two isolates, which has involved a PKS gene cluster. Two 
other PKS sequences amplified from these isolates, MP6A2 PKSI-2 and MP6D1 PKSI-2, encoded KS 
domains showing 94% and 96% identity, respectively, to the PKS and NRPS-PKS proteins encoded by 
two different gene clusters in Streptomyces griseus subsp. griseus NBRC 13350 [37]. Interestingly, the 
MPS06-A2 PKSI-2 sequence displayed 94% identity to the MP8E7 PKSI-5 sequence, also suggesting 
a relatively recent transfer of the corresponding gene between MP6A2 and MP8E7 isolates.  
Isolates MP6A8, MP6C6, MP6C10 and MP9E12 each yielded one distinct KS domain encoding 
sequence. MP6A8 and MP6C6 PKSI sequences were 98% identical, suggesting recent horizontal gene 
transfer, and displayed 83% identity to the PKS type I from the cryptic gene cluster from S. coelicolor. 
The latter gene was different from the one showing closest match to the MP6A2/D1 PKS-1 sequences 
(see above), although apparently belonged to the same PKS cluster.  
Both MP6C10 and MP9E12 PKS sequences were closely related (96% and 98% identity, 
respectively), to the NRPS-PKS fusion protein from Streptomyces griseus subsp. griseus NBRC 13350 
[37]. They were also very similar to the PKS sequences MP6A2 PKSI-2 and MP8E7 PKSI-5, showing 
93% and 96% identity, respectively.  
In order to visualize taxonomic relationship between the amino acid sequences encoded by the 
PCR-amplified fragments, a phylogenetic tree was constructed, which also included sequences from 
the best matches according to the BLAST search. The architecture of the tree, presented in Figure 3, 
clearly shows some discrepancy between the BLAST search and the phylogenetic analysis. For 
example, the PKSI-1,-2,-3 and -6 sequences from the isolate MP8E7 do not cluster with the 
corresponding best matches from the BLAST search, and form a separate branch on the tree. This 
suggests that the PKS gene cluster represented by these sequences might have evolved separately, and 
potentially can encode a novel polyketide metabolite. Mar. Drugs 2008, 6 
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 Figure 3. Phylogenetic relationship between PKS type I amino acid sequences from 
streptomycete isolates with identical partial 16S rDNA sequences. Closest matches from 
the BLAST searches are also included. Putative distinct KS domain types are indicated 
with letters (A, B, C etc). Numbers at tree nodes represent the number of times the 
topology to the right of the node was recovered in 1000 bootstrap re-samplings. 
Accession numbers for the sequences are given in parentheses. Scale bar represents the 
number of changes per amino acid position. 
 
 MP6A8 PKSI
 MP6C6 PKSI
 PKSI S. coelicolor (NP630373)
 PteA2 S. avermitilis (BAB69304)
 MerC S. violaceusniger (ABJ97439)
 PKS I Sac. erythraea (YP001106333)
 MP8E7 PKSI-4
 PKS I A. orientalis (ABM47024)
 PKSI S. coelicolor(NP630372)
 MP6A2 PKSI-1
 MP6D1 PKSI-1
 MP8E7 PKSI-2
 MP8E7 PKSI-3
 MP8E7 PKSI-1
 MP8E7 PKSI-6
 MP6D1 PKSI-2
 PKS I S. griseus (YP001828290) 
 MP6A2 PKSI-2
 MP8E7 PKSI-5
 MP6C10 PKSI
 NRPS/PKS S. griseus (YP001822326) 
 MP9E12 PKSI
100
50
76
44
100
100
100
100
99
97 
80
98 
64
100 
45 
22 
54 
31 
27 
0.1
 
  Both BLAST and phylogenetic analyses suggest that we have been able to identify 6 distinct types 
of KS domains in 7 closely related (according to the 16S rDNA sequences) isolates. This does not 
necessarily mean that each type represents a distinct PKS gene cluster. In phylogenetic analysis, the 
KS domains are known to cluster not only according to their evolutionary relatedness, but also 
according to their substrate specificity [38]. Interestingly, one of the KS types belonging to the NRPS-
PKS fusion protein (F) seems to be shared by at least 4 isolates and its coding DNA might have been 
subject to a relatively recent horizontal gene transfer. There is, however, no correlation between the 
presence of this KS type and antimicrobial activity profiles of the four isolates (Table 3). The latter 
suggests that the corresponding PKS cluster might be either not expressed in the conditions tested, or 
governs biosynthesis of a compound which is not detectable by the assays employed. The same might 
A
B
C
D
E
FMar. Drugs 2008, 6 
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be true for the KS type C represented by the sequences MP6A2 PKSI-1 and MP6D1 PKSI-1, since the 
corresponding isolates have different inhibition patterns (see Table 3).  
  The analyses of the KS domains from selected isolates with identical 16S rDNA sequences do not 
enable solid conclusions about the nature of the compounds that may potentially be produced. 
However, the fact that unique KS types, such as B, D and E, seem to be isolate-specific, further 
supports the notion that streptomycete isolates can not be distinguished on the basis of 16S rDNA 
sequences alone. A more complex approach that includes PCR-based PKS and NRPS genome 
“scanning”, inoculation in a wide range of growth/production media, metabolite profiling and diverse 
biological assays with fractionated extracts is required to reveal the true potential for production of 
medically useful secondary metabolites.  
3. Experimental Section 
3.1. Sampling and isolation of Streptomycete bacteria from sea surface microlayer (Sampling sites and 
sample collection) 
Samples were collected on the 22
nd of March 2004 at two sites (63°32,511 N, 010°48,797 E and 
63º56,009 N, 010º91,020 E) in the Trondheim fjord, Norway. Steinvikholmen (sample 1) is a small 
islet situated approximately 200 m from the mainland, whereas the other sampling point was close to 
shore. The surface microlayer was collected using Teflon plates as earlier described [39]. The plates 
were immersed in water, gently lifted through the water surface, and the bacterioneuston scraped off 
using a rubber edge. Both samples were collected early in the morning during low tide, and 2 to 3 
meters from the shoreline.  
Samples were plated on selective agar plates (2% w/v), within 24 hours after collection, and was 
incubated at 20 ºC. Three different media was used; ½ ISP2; Malt extract (5 g), yeast extract (2 g), 
glucose (2 g), natural sea water (0.5 L) and distilled water (0.5 L), Kusters streptomycete isolation 
medium (modified); Glycerol (10 g), Casein (0.3 g), KNO3 (2 g), FeSO4*7 H2O (0.25 mg), H2SO4 (0.5 
mg), natural sea water (0.5 L) and distilled water (0.5 L) and Actinomycete isolation medium without 
MgSO4 [40]. The pH of the isolation media was adjusted to pH 8.2. All media contained 50% sea 
water and was supplied with Cycloheximide (50 µl/ml) and Nalidixic acid (30 µl/ml). Selected isolates 
were transferred to ½ ISP2 agar to ensure pure colonies, and incubated for 16 days before storing as 
glycerol stock in micro well plates at -80 °C.  
3.2. Extraction and antimicrobial assay 
The selected strains were transferred to microwell filter plates (Nunc Silent screen nr 256073, 
Loprodyne 3.0 μm) with 80 µl of three different 1% agarose media (production media) to facilitate 
production of secondary metabolites. The production media (PM) were: PM2; Mannitol (20 g), soya 
bean flour (20 g), Clerol (antifoam, 0.5 g), dry yeast (3.4 g), agarose (10.0 g), tap water (1 L), PM3; 
Oatmeal (20 g), glycerol (2.5 g), FeSO4·7H2O (0.1 mg), MnCl2·4H2O (0.1 mg), ZnSO4·7H2O (0.01 
mg), H2SO4 (0.1 mg), agarose (10 g), tap water (1 L), PM4; glucose (0.5 g), glycerol (2.5 g), oatmeal 
(5.0 g), soybean meal (5.0 g), yeast extract (1 g), casaminoacids (2.0 g), CaCO3 (1.0 g), Clerol (0.2 g), 
agarose (10 g) and tap water (1 L). Mar. Drugs 2008, 6 
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After an appropriate incubation time, 3 mm glass beads were added to the plates, and the strains 
were dried in the dark over night before extraction with 150 µl DMSO. The plates were shaken for 2 h 
at 1000 rpm before vacuum filtration (Event 4160, Eppendorf). These extracts were stored at -20 °C, 
and tested in agar diffusion assays for content of antagonistic compounds active against Micrococcus 
luteus (ATCC 9341), Candida albicans (ATCC 10231) and Escherichia coli K12 . 
A variant of Burkholder agar diffusion assay [41] was used when screening for antimicrobial activity. 
Indicator agarose was prepared by mixing 1% agarose medium with 0.5-1% v/v indicator organism 
culture (OD600 = 3,6 M. luteus, 5,0 C. albicans, 3,0 E. coli.), and poured into Petri dishes. LB agarose medium 
was used for E. coli, M19 for C. albicans and M1 for M. luteus. The media contained: M1; peptone 
(6.0 g), trypton (4.0 g), yeast extract (3.0 g), beef extract (1.5 g), dextrose (1.0 g), agarose (10 g) and 
tap water (1 L), pH 6,6. M19; beef extract (2.4 g), yeast extract (4.7 g), peptone (9.4 g), dextrose (10.0 
g), NaCl (10.0 g), agarose (10 g) and tap water (1 L), pH 6,1. 
DMSO-extracts were stamped manually from microwell plates onto the indicator agarose with the 
selected indicator organism. Approximately 2 µl of each extract was applied onto plates with 1.3 cm 
thick indicator agarose. The plates were preincubated for 3 to 4h at 4 °C, before incubating at 30 ºC 
over night. Extracts were defined as inhibiting if inhibition zones were ≥ 2mm larger than the diameter 
of the applied sample.  
 3.3 Cloning, sequencing and phylogenetic analysis 
Based on morphology and inhibition patterns from the antimicrobial assays, subgrouping was 
performed, and candidates from each subgroup sequenced. PCR was performed directly on colonies or 
with isolated total-DNA as template. Total-DNA of the bacteria was isolated using DNeasy Blood & 
Tissue Kit (Qiagen) according to manufacturer’s protocol. 
The primers BP_F27: 5’-AGA GTT TGA TCM TGG CTC AG-3’ and BP_R1492: 5’-TAC GGY 
TAC CTT GTT ACG ACT T-3’ [42], were used to amplify 1,5 kb of the 16S rRNA gene. The PCR 
was performed using initial denaturation at 94 °C for 4 minutes, followed by 35 cycles of 94 °C for 45 
seconds, 55 °C for 20 seconds and 66 °C for 2 minutes. A final extension was performed at 70 °C for 5 
minutes. PCR products were purified directly or after excision from agarose gel, using QIAquick Spin 
Kits according to the manufacturer’s instructions (Qiagen). Purified PCR-products were transformed 
into E. coli EZ competent cells after ligation into the pDrive cloning vector using the QIAGEN PCR-
cloning Kit (Qiagen). 
The 16S rRNA fragments were sequenced either from the pDrive-clones or directly after PCR. The 
primer M13 reverse: 5'-AACAGCTATGACCATG-3' described in the Qiagen PCR Cloning Handbook 
(04/2001) was used for the pDrive-clones. Sequencing directly on the PCR products were performed 
with the same primers as for the PCR. The sequencing was performed using BigDye® Terminator v3.1 
Cycle Sequencing Kit (Applied Biosystems). The sequencing program consisted of a initial step at 96 
°C for 3 minutes, and 25 cycles of 96 °C for 30 seconds, 50 °C for 20 seconds and 60 °C for 4 minutes.  
The phylogenetic analyses of the cloned sequences were performed using MEGA 4. A phylogenetic 
tree was constructed using neighbour-joining with 500 bootstrap replicates. Comparisons of the 
sequences with other available 16S rDNA sequences were done by BLAST searches to determine Mar. Drugs 2008, 6 
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strain homology. The 16S rDNA sequence from Micromonospora sp DSM 44397 was included to root 
the tree.  
3.4 PCR amplification of PKS and NRPS-genes 
Bacterial modular type I PKS genes were amplified with the degenerate primers KSMA-F (5’-TS 
GCS ATG GAC CCS CAG CAG-3’) and KSMB-R (5’-CC SGT SCC GTG SGC CTC SAC-3’) [31]. 
PCR with these primers, amplifying the β-ketoacyl synthase (KS) domain (~700 bp), was performed 
using initial denaturation at 96 ˚C for 5 min, 35 cycles of 95 ºC for 1 min, 60 ºC for 1 min and 72ºC for 
2 min. Final extension was performed at 72 ºC for 5 min.  
For each reaction 200 µM dNTPs 20-40 ng total-DNA and 200 nM of each primer were used. 
Cloning of the fragments was performed as described for 16S rDNA Sequencing was performed by 
Eurofins MWG Operon. 
3.5 Nucleotide sequence accession numbers 
DNA sequences reported in this study have been deposited to GenBank under accession numbers 
FJ190540-FJ190569 
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